Issue Contents:  Aug 21, 2009

• Washington roundup: Durolane application damaged by choice of control article
• Growing neurostimulation sector is opportunity for device makers
• International report: Staar still waiting for Japanese approval of its Visian ICL products
• Protect your med-tech firm with anti-corruption compliance plan
• Financings roundup: Coherex Medical closes on $16.5M Series B Preferred Stock funding
• Today's MDD food for med-tech thought
• Agreements/contracts: AdvanSource Biomaterials lands deal with international device firm
• Court report: Two defendants plead guilty in Medicare conspiracy case
• New ventures: AMDL launches diagnostics branch to focus on Onko-Sure
• Grants roundup: U.S. doles out $1.2B in funding to help implement EHRs in hospitals
• Product Briefs
• WorldHeart to start study of Levacor ventricular device
• MDD's Diagnostic Extra

      The above issue is also available as one PDF File